FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3019405611> ?p ?o ?g. }

• W3019405611 endingPage "1046" @default.
• W3019405611 startingPage "1046" @default.
• W3019405611 abstract "Oligoprogression (OPD) of non-small-cell lung cancer (NSCLC) occurs in approximately half of patients under targeted compounds (TKI) and facilitates use of regional therapies that can prolong survival. In order to characterize OPD in immunotherapy (IO)-treated NSCLC, we analyzed the failure pattern under PD-1/PD-L1 inhibitors (n = 297) or chemoimmunotherapy (n = 75). Under IO monotherapy, OPD was more frequent (20% vs. 10%, p < 0.05), occurred later (median 11 vs. 5 months, p < 0.01), affected fewer sites (mean 1.1 vs. 1.5, p < 0.05), and involved fewer lesions (1.4 vs. 2.3, p < 0.05) in the first compared to later lines. Lymph nodes (42%, mainly mediastinal) and the brain (39%) were mostly affected, followed by the lung (24%) and other organs. Compared to multifocal progression, OPD occurred later (11 vs. 4 months, p < 0.001) and was associated with longer survival (26 vs. 13 months, p < 0.001) and higher tumor PD-L1 expression (p < 0.001). Chemoimmunotherapy showed a similar incidence of OPD as IO monotherapy (13% vs. 11% at 2 years). Local treatments were applied regularly for brain but only in 50% for extracranial lesions. Thus, NSCLC oligoprogression is less common under IO than under TKI, but also favorable. Since its frequency drops later in the disease, regular restaging and multidisciplinary evaluation are essential in order to exploit the full therapeutic potential." @default.
• W3019405611 created "2020-05-01" @default.
• W3019405611 creator A5010144158 @default.
• W3019405611 creator A5013804417 @default.
• W3019405611 creator A5018231423 @default.
• W3019405611 creator A5021850789 @default.
• W3019405611 creator A5024585720 @default.
• W3019405611 creator A5025473299 @default.
• W3019405611 creator A5026607584 @default.
• W3019405611 creator A5027488275 @default.
• W3019405611 creator A5042715286 @default.
• W3019405611 creator A5047087649 @default.
• W3019405611 creator A5053291675 @default.
• W3019405611 creator A5055278162 @default.
• W3019405611 creator A5071565360 @default.
• W3019405611 creator A5078217749 @default.
• W3019405611 creator A5085505239 @default.
• W3019405611 creator A5088692910 @default.
• W3019405611 date "2020-04-23" @default.
• W3019405611 modified "2023-10-11" @default.
• W3019405611 title "Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors" @default.
• W3019405611 cites W1969531640 @default.
• W3019405611 cites W1979536922 @default.
• W3019405611 cites W2019607817 @default.
• W3019405611 cites W2027242209 @default.
• W3019405611 cites W2030227571 @default.
• W3019405611 cites W2033672531 @default.
• W3019405611 cites W2139483106 @default.
• W3019405611 cites W2482427906 @default.
• W3019405611 cites W2497746146 @default.
• W3019405611 cites W2536331410 @default.
• W3019405611 cites W2570361299 @default.
• W3019405611 cites W2607272476 @default.
• W3019405611 cites W2624310346 @default.
• W3019405611 cites W2737082469 @default.
• W3019405611 cites W2766874979 @default.
• W3019405611 cites W2790646620 @default.
• W3019405611 cites W2796327298 @default.
• W3019405611 cites W2796582438 @default.
• W3019405611 cites W2797931455 @default.
• W3019405611 cites W2799401120 @default.
• W3019405611 cites W2884574159 @default.
• W3019405611 cites W2889444510 @default.
• W3019405611 cites W2894476389 @default.
• W3019405611 cites W2902389984 @default.
• W3019405611 cites W2904516836 @default.
• W3019405611 cites W2909729931 @default.
• W3019405611 cites W2910245285 @default.
• W3019405611 cites W2910636472 @default.
• W3019405611 cites W2915789858 @default.
• W3019405611 cites W2921755569 @default.
• W3019405611 cites W2942955398 @default.
• W3019405611 cites W2950824232 @default.
• W3019405611 cites W2955649100 @default.
• W3019405611 cites W2977498449 @default.
• W3019405611 cites W2978609674 @default.
• W3019405611 cites W2979677359 @default.
• W3019405611 cites W2995281612 @default.
• W3019405611 cites W2995626174 @default.
• W3019405611 cites W2996463763 @default.
• W3019405611 doi "https://doi.org/10.3390/cancers12041046" @default.
• W3019405611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7226015" @default.
• W3019405611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32340408" @default.
• W3019405611 hasPublicationYear "2020" @default.
• W3019405611 type Work @default.
• W3019405611 sameAs 3019405611 @default.
• W3019405611 citedByCount "44" @default.
• W3019405611 countsByYear W30194056112020 @default.
• W3019405611 countsByYear W30194056112021 @default.
• W3019405611 countsByYear W30194056112022 @default.
• W3019405611 countsByYear W30194056112023 @default.
• W3019405611 crossrefType "journal-article" @default.
• W3019405611 hasAuthorship W3019405611A5010144158 @default.
• W3019405611 hasAuthorship W3019405611A5013804417 @default.
• W3019405611 hasAuthorship W3019405611A5018231423 @default.
• W3019405611 hasAuthorship W3019405611A5021850789 @default.
• W3019405611 hasAuthorship W3019405611A5024585720 @default.
• W3019405611 hasAuthorship W3019405611A5025473299 @default.
• W3019405611 hasAuthorship W3019405611A5026607584 @default.
• W3019405611 hasAuthorship W3019405611A5027488275 @default.
• W3019405611 hasAuthorship W3019405611A5042715286 @default.
• W3019405611 hasAuthorship W3019405611A5047087649 @default.
• W3019405611 hasAuthorship W3019405611A5053291675 @default.
• W3019405611 hasAuthorship W3019405611A5055278162 @default.
• W3019405611 hasAuthorship W3019405611A5071565360 @default.
• W3019405611 hasAuthorship W3019405611A5078217749 @default.
• W3019405611 hasAuthorship W3019405611A5085505239 @default.
• W3019405611 hasAuthorship W3019405611A5088692910 @default.
• W3019405611 hasBestOaLocation W30194056111 @default.
• W3019405611 hasConcept C120665830 @default.
• W3019405611 hasConcept C121332964 @default.
• W3019405611 hasConcept C121608353 @default.
• W3019405611 hasConcept C126322002 @default.
• W3019405611 hasConcept C143998085 @default.
• W3019405611 hasConcept C2776256026 @default.
• W3019405611 hasConcept C2777701055 @default.
• W3019405611 hasConcept C2780790343 @default.
• W3019405611 hasConcept C61511704 @default.

• next